Menu
Back to Journals » Vascular Health and Risk Management » Volume 14
Review
Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,220 | Dovepress* | 7,419+ | 1,716 | 9,135 | |
| PubMed Central* | 1,801 | 366 | 2,167 | ||
| Totals | 9,220 | 2,082 | 11,302 | ||
| *Since 7 December 2018 | |||||
View citations on PubMed Central and Google Scholar